Redeye comments on FluoGuide’s Q3 2025 report. The company has posted a busy news flow in recent mon...
Redsense Medical fortsätter att växa trots valutamotvind, med en stark Q3-förbättring både i omsättn...
* Strategic pivot into the SOFC market * Rights issue of ~SEK 87.
Top Picks comments on a significant development that fundamentally changes one of our investment the...
Vi inleder bevakning på Beyond Frames, en svensk spelutvecklare och publisher inom XR, en samlingste...
Redeye provides a research update following the recently published Q3 report from Lipum.
Redeye comments on yesterday’s cash offer of SEK45 per share from Aneo.
* European Commission drafts proposal for non-renewal of Selektope * Limited impact on near-term est...
Redeye provides an in-depth update on AcouSort following the company’s Q3 report.
Redeye updates its estimates and fair value range following Xplora’s Q3 report, which surprised posi...
Xplora reported strong demand for its products and subscriptions in the Q3 report, and it reported g...
Case Group rapporterade sitt starkaste kvartal någonsin med stark tillväxt, stabila kapitalflöden oc...
* NetApp +5% on EPS beat, but reiterated low growth revenue guidance * Dell +3%, storage revenues de...
Redeye takes a positive stance towards Hexatronic’s US Data Center acquisition, adding geographical ...
Redeye notes that Xplora’s third-quarter report marks a distinct inflection in profitability, with a...
* Q3: high GM, but soft device sales and ARPU * Doro conversion rate 25% in D2C channels (13% in Q2)...
Xplora's gross profit came in stronger than expected at NOK 263m, 4% higher than consensus, driven b...
Redeye comments on the recently announced continuing restructuring of the Wellness division, which r...
Redeye initiates coverage of Ferroamp, a greentech company offering a modular hardware and software ...